Business Standard

Saturday, December 21, 2024 | 05:27 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Gold plunges 5% over Covid-19 vaccine success as investors dump bullion

Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar

Gold
Premium

Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session.

Reuters
Gold slumped more than 5 per cent on Monday as news of the first successful late-stage Covid-19 vaccine trials prompted investors to dump safe-haven bullion and flock to riskier assets.

Spot gold was down 5.1 per cent at $1,852.82 per ounce by 11:07 a.m. EDT (1607 GMT), while U.S. gold futures slid 4.9 per cent to $1,855.30.

Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar and hopes for more stimulus following Joe Biden's victory in the U.S. elections.

Equities surged after Pfizer Inc said its experimental Covid-19 vaccine was

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in